Atlas Trials

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

Clinical trial NCT00877149 · COMPLETED

Trial details

NCT number
NCT00877149
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Compensated Chronic Hepatitis B
Start date
2009-03-01
Primary completion
2011-04-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.